Cc1cn(C2CC(n3cc(Cn4cc(I)c(=O)[nH]c4=O)nn3)C(CO)O2)c(=O)[nH]c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?